9:45 a.m.

Opening Ceremony
BSC President – Jadelson Andrade
Dr. Fuster

10:15 a.m.

Welcome and Introduction
Dr. Fuster

Session I

New Discoveries in Athero-thrombogenesis
Dr. Roberts, Presiding

10:30 a.m.

Impact of The HIGH RISK PLAQUE Non Invasive Bioimage Study
Subclinical Macro/Micro Vascular Disease – Heart & Brain
Dr. Fuster

10:55 a.m.

Impact of the PROSPECTIVE and YELLOW Invasive Imaging Studies Understanding of Native Atherosclerosis & Stenting Deployment
Dr. Sharma

11:15 a.m.

Evolving Impact of OMICS in Approaching CV Disease
A Step-by-Step Building Process
Dr. Roberts

11:40 a.m.

Impact of NEW ANTITHROMBOTICS on the Benefit/Bleeding Ratio
High Ratio in Preventing AF - Stroke, Low Ratio in CAD - Thrombosis
Dr. Harrington

12:05 p.m.

Panel Discussion
Drs. Fuster, Harrington, Roberts and Sharma

Session II

Acute Coronary Syndromes
Dr. Harrington, Presiding

02:05 p.m.

STEMI - Clock Time Reperfusion Strategies and Evolving Ambulance Therapy Targeted at Myocardial Demand
Dr. Harrington

02:30 p.m.

NSTEMI-ACS – Stenting/Non Stenting Strategies and Adjunctive Management
Dr. Sharma

02:55 p.m.

The Evolving Science of Stents
The 2012-2013 Data of New Stents – Any Convincing Advance?
Dr. Sharma

03:15 p.m.

Panel Discussion
Drs. Harrington and Sharma

Session III

Chronic Coronary and Systemic Arterial Disease
Challenges of Management and Prevention
Dr. Smith, Presiding

04:05 p.m.

The FREEDOM Trial as a Model for Complex CAD
Management Based on Anatomy, Flow and Co-morbidities
Dr. Fuster

04:30 p.m.

Stable Angina in the Younger and the Older
Dr. Harrington

04:50 p.m.

Evolving Guidelines on Lipids as Seen by The Chairman
Predicting Further Lowering of LDL-C and Can Low HDL-C Treatment Resuscitate?
Dr. Smith

05:15 p.m.

Evolving Guidelines on Hypertension and New Approaches
From Population Salt Reduction to Personalized Treatment Targets
Dr. Smith

05:40 p.m.

Renal Sympathetic Denervation
The 2012-2013 Data on Hypertension and Applications Beyond
Dr . Reddy

06:10 p.m.

The Link Between Diabetes and Obesity
Are we Ready for Bariatric Surgery?
Dr. Smith

06:35 p.m.

Promoting Cardiovascular Health Challenges
Pre-School Children, the Adult Community, the Polypill
Dr. Fuster

07:00 p.m.

Panel Discussion
Drs. Fuster, Harrington, Reddy and Smith

7h30

Exhibition Tour

Session IV

Systolic & Diastolic Heart Failure and Pulmonary Hypertension Basis for Management
Dr. Yancy, Presiding

08:00 a.m.

Evolving Diagnostic and Prognostic Imaging (MR, CT) of the Various Cardiomyopathies: Myocarditis, Dilated, Infiltrative (Amyloid, Sarcoid), Hypertrophic, Noncompaction
Dr. Bonow

08:20 a.m.

Systolic Dysfunction – Clinical / Hemodynamic Guide for Management New Medical and Interventional Therapeutic Challenges
Dr. Yancy

08:35 a.m.

Diastolic Dysfunction – Clinical/ Echo Guide for Management Etiology/Comorbidities are the Medical Therapeutic Challenge
Dr. Yancy

08:50 a.m.

Role of ICD/ CRT Therapies in Systolic and Diastolic Dysfunction
The 2012- 2013
Update
Dr. Reddy

09:10 a.m.

Destination LVADs
A Rapidly-Evolving Alternative to Heart Transplantation
Dr. Yancy

09:30 a.m.

Current Status and Future Directions of Pulmonary Hypertension
Recognition of the Structural Etiology and Hemodynamics
Dr. Sorajja

09:50 a.m.

Panel Discussion
Drs. Bonow, Reddy, Sorajja and Yancy

Session V

Rhythm Disorders, Contemporary and Future Topics of Focus
Dr. Reddy, Presiding

10:35 a.m.

VT, Scar Related (MRI) - Contemporary Management
Catheter Ablation, Emerging Clinical Evidence
Dr. Reddy

10:55 a.m.

Atrial Fibrillation – Clinical Considerations
Quality of Life and Preventing Stroke
Dr. Fuster

11:15 a.m.

Atrial Fibrillation - Catheter Ablation
Outcome as a Function of the Disease Substrate
Dr. Reddy

11:35 p.m.

Atrial Fibrillation – Stroke Prevention Beyond Anticoagulation
Latest Evidence With Catheter Ablation & LA Appendage Closure
Dr. Reddy

11:55 p.m.

Panel Discussion
Drs. Fuster and Reddy

12:15 p.m.

Break

Valvular Heart Disease and Aorta — Challenges in 2013

Session VI

Understanding and Management of Aortic Valve Disease
Dr. Ommen, Presiding

01:45 p.m.

Aortic Stenosis – Challenges in Evaluation & Management
Asymptomatic Severe and Symptomatic Low Flow/Low Gradient
Dr. Bonow

02:00 p.m.

The Best Aortic Prosthetic Valve Choice for a 45-year-old: Mechanic?, Pericardial (TAVI Later if Degenerates)?, Ross Procedure?
Dr. Sorajja

02:15 p.m.

Transcatheter AVR, Present Status Just for the Elderly High
Risk ?
Dr. Anyanwu

02:30 p.m.

Transcatheter AVR, Future Roles ? The Younger Low Risk ?, Aortic Insufficiency?
Dr. Sharma

02:45 p.m.

Aortic Regurgitation - State of the Art Management
Dr. Ommen

03:00 p.m.

When to Replace the Root ? The Dilated Aorta and Its Consequences:
Dr. Fuster

03:15 p.m.

Panel Discussion
Drs. Anyanwu, Bonow, Fuster, Ommen, Sorajja and Sharma

Session VII

Management of IHSS and Mitral Regurgitation
Dr. Bonow, Presiding

04:05 p.m.

State-of-the-Art Management of IHSS & Non-Compaction LV: Pharmacological, Septal Reduction (Alcohol, Myectomy)
Dr. Ommen

04:20 p.m.

Severe Mitral Regurgitation – The Clinician’s View It May Be Too Early or Too Late for Operation
Dr. Bonow

04:35 p.m.

Severe Mitral Regurgitation – The Surgeon’s View Aiming for a Successful Surgical Repair Any Future for Percutaneous Repair, Starting with Functional MR ?
Dr. Anyanwu

04:50 p.m.

Panel Discussion
Drs. Anyanwu, Bonow and Ommen

05:10 p.m.

Closing Lecture A Perspective of Genetics and Tissue Regeneration in 2013
Dr. Fuster